Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

3.75
Delayed Data
As of Aug 31
 +0.07 / +1.90%
Today’s Change
0.65
Today|||52-Week Range
5.76
+68.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

--

--
Revenue and IncomeNet Revenues0.000.00------
Depreciation And Amortization0.001.3K----
 
 
 
Operating ExpensesGross Income0.00-1.3K----
 
 
General Expenses140.2K1.7M----
 
 
 
Research And Development17.7K314.2K----
 
 
 
Total Operating Expenses140.2K1.7M----
 
 
 
 
Non-Operating ExpensesOperating Income-140.2K-1.7M----
 
 
 
Extraordinary Charge0.00-3.6M----
 
 
Interest Expense On Debt328.0012.9K----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-140.5K-5.3M----
 
 
 
Net Income-140.5K-5.3M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.0M12.8M----
 
 
 
Shares To Calculate EPS Diluted9.0M12.8M----
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.41----
 
 
 
EPS Diluted-$0.02-$0.41----